NEUVAX Trademark

Trademark Overview

On Wednesday, September 24, 2014, a trademark application was filed for NEUVAX with the United States Patent and Trademark Office. The USPTO has given the NEUVAX trademark a serial number of 86404420. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 28, 2018. This trademark is owned by Galena Biopharma, Inc.. The NEUVAX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and vaccines for the treatment of cancer
neuvax

General Information

Serial Number86404420
Word MarkNEUVAX
Filing DateWednesday, September 24, 2014
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 28, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 24, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations and vaccines for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 2, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGalena Biopharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPortland, OR 97239
Party NameGalena Biopharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPortland, OR 97239

Trademark Events

Event DateEvent Description
Tuesday, May 29, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, May 28, 2018ABANDONMENT - NO USE STATEMENT FILED
Thursday, October 26, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 25, 2017EXTENSION 5 GRANTED
Wednesday, October 18, 2017EXTENSION 5 FILED
Wednesday, October 18, 2017TEAS EXTENSION RECEIVED
Tuesday, October 17, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, April 22, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 20, 2017EXTENSION 4 GRANTED
Thursday, April 20, 2017EXTENSION 4 FILED
Thursday, April 20, 2017TEAS EXTENSION RECEIVED
Thursday, April 20, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 9, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 8, 2016EXTENSION 3 GRANTED
Thursday, October 20, 2016EXTENSION 3 FILED
Thursday, October 20, 2016TEAS EXTENSION RECEIVED
Tuesday, May 17, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 16, 2016EXTENSION 2 GRANTED
Thursday, April 14, 2016EXTENSION 2 FILED
Thursday, May 12, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, April 14, 2016TEAS EXTENSION RECEIVED
Friday, October 9, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 7, 2015EXTENSION 1 GRANTED
Wednesday, October 7, 2015EXTENSION 1 FILED
Wednesday, October 7, 2015TEAS EXTENSION RECEIVED
Tuesday, April 21, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 24, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 24, 2015PUBLISHED FOR OPPOSITION
Wednesday, February 4, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 13, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 13, 2015ASSIGNED TO EXAMINER
Thursday, October 2, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM

Related Keywords

neuvax cancer treatment vaccines preparations pharmaceutical